Recognition of normal, neoplastic, and fetal airway epithelial cell membranes by two monoclonal antibodies.
The reactivity of two rat monoclonal antibodies was studied. These antibodies, A2R and A2C, bind a 32 kDa alveolar type II cell membrane receptor for surfactant protein A. A2R and A2C also bind apical cell membranes of ciliated and nonciliated cells of the conducting airways. Because this reactivity suggested possible utility in targeting those cells for therapeutic gene transfer, the binding activity of these two antibodies was examined in human tissues. In conducting airways, A2R and A2C bound apical epithelial cell membranes throughout the embryologic period studied: from 15 weeks of gestation, through maturity. Reactivity was more restricted to ciliated cells of the airways as maturation progressed. In the peripheral lung, A2C and A2R only bound most cells in the early developing lung, but mainly type II cells in mature lungs. Other normal tissues recognized by these antibodies included crypt lining cells of the adult and fetal stomach, large bile duct epithelium, and pancreatic acinar cells. All of these cells derive from embryonic foregut endoderm. Other normal tissues, both of endodermal and nonendodermal origin, were negative. Pulmonary carcinomas were studied. A2C and A2R recognized all non-small cell carcinomas of the lung tested. In contrast, none of the small cell carcinomas or carcinoid tumors of the lung were recognized by these antibodies. The function of p32 in these diverse cell types is not clear, but whatever its role in these tissues, antibodies versus p32 may potentially be used to target gene or drug therapy to the normal or malignant cells they recognize.
Strayer
D S
DS
Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Philadelphia, PA 19107, USA.
Schwarting
R
R
D000328:Adult; D000911:Antibodies, Monoclonal; D002462:Cell Membrane; D004848:Epithelium; D005333:Fetus; D006801:Humans; D007150:Immunohistochemistry; D008168:Lung / Q000737:chemistry / Q000196:embryology* / Q000473:pathology*; D008175:Lung Neoplasms / Q000737:chemistry / Q000473:pathology; D008565:Membrane Proteins / Q000032:analysis / Q000276:immunology; D011510:Proteolipids / Q000032:analysis* / Q000276:immunology; D011650:Pulmonary Alveoli / Q000737:chemistry / Q000196:embryology / Q000473:pathology; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000032:analysis* / Q000276:immunology
D000911:Antibodies, Monoclonal; D008565:Membrane Proteins; D011510:Proteolipids; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants